| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A FAM13B TBC1D3C TBC1D3B TBC1D9 RASGRP3 TBC1D3I ARHGAP8 TBC1D3G TBC1D3K TBC1D3F | 1.70e-11 | 279 | 123 | 16 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E PSD2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A ECT2L FAM13B TBC1D3C TBC1D3B TBC1D9 RASGRP1 RASGRP3 TBC1D3I ARHGAP8 TBC1D3G VAV2 TBC1D3K TBC1D3F | 3.83e-11 | 507 | 123 | 20 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E PSD2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A ECT2L FAM13B TBC1D3C TBC1D3B TBC1D9 RASGRP1 RASGRP3 TBC1D3I ARHGAP8 TBC1D3G VAV2 TBC1D3K TBC1D3F | 3.83e-11 | 507 | 123 | 20 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A FAM13B TBC1D3C TBC1D3B TBC1D9 RASGRP3 TBC1D3I ARHGAP8 TBC1D3G TBC1D3K TBC1D3F | 2.78e-06 | 656 | 123 | 16 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E PSD2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A CCNP ECT2L ADGRV1 FAM13B TBC1D3C TBC1D3B TBC1D9 RASGRP1 IBTK RASGRP3 AKT1 TBC1D3I ARHGAP8 TBC1D3G VAV2 TBC1D3K TBC1D3F | 5.04e-06 | 1418 | 123 | 24 | GO:0030234 |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 2.74e-04 | 51 | 123 | 4 | GO:0001784 | |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 3.72e-04 | 5 | 123 | 2 | GO:0035731 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 4.19e-04 | 363 | 123 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A FAM13B TBC1D3C TBC1D3B TBC1D9 RASGRP3 PRKACA AKT1 TBC1D3I ARHGAP8 TBC1D3G TBC1D3K TBC1D3F | 5.48e-04 | 1233 | 123 | 18 | GO:0140677 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF13B RAB11B KIF6 MTG2 WRN RAB11A ATAD2 ATL1 KIF3A GPN2 MCM9 SMARCA4 ENPP5 GNA15 | 6.63e-04 | 839 | 123 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF13B RAB11B KIF6 MTG2 WRN RAB11A ATAD2 ATL1 KIF3A GPN2 MCM9 SMARCA4 ENPP5 GNA15 | 6.71e-04 | 840 | 123 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF13B RAB11B KIF6 MTG2 WRN RAB11A ATAD2 ATL1 KIF3A GPN2 MCM9 SMARCA4 ENPP5 GNA15 | 6.71e-04 | 840 | 123 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 7.75e-04 | 7 | 123 | 2 | GO:0004769 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 7.75e-04 | 7 | 123 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 8.70e-04 | 69 | 123 | 4 | GO:0045309 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B RAB11B KIF6 MTG2 WRN RAB11A ATAD2 ATL1 KIF3A GPN2 MCM9 SMARCA4 GNA15 | 9.90e-04 | 775 | 123 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 1.32e-03 | 9 | 123 | 2 | GO:0004690 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.32e-03 | 9 | 123 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B KIF6 MYO9A WRN ATAD2 KIF3A MCM9 SMARCA2 SMARCA4 HELZ ATP6V0A2 | 1.46e-03 | 614 | 123 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 1.64e-03 | 10 | 123 | 2 | GO:0004679 | |
| GeneOntologyMolecularFunction | channel activator activity | 1.64e-03 | 10 | 123 | 2 | GO:0099103 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.78e-03 | 446 | 123 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | mismatch repair complex binding | 2.00e-03 | 11 | 123 | 2 | GO:0032404 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 2.20e-03 | 42 | 123 | 3 | GO:0071889 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 2.31e-03 | 149 | 123 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | transporter activator activity | 2.39e-03 | 12 | 123 | 2 | GO:0141109 | |
| GeneOntologyMolecularFunction | arrestin family protein binding | 2.39e-03 | 12 | 123 | 2 | GO:1990763 | |
| GeneOntologyMolecularFunction | helicase activity | 2.97e-03 | 158 | 123 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 3.04e-03 | 47 | 123 | 3 | GO:0004712 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D9 CRK CRKL RASGRP1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.28e-16 | 109 | 124 | 15 | GO:0090630 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A PLXND1 TBC1D3C TBC1D3B TBC1D9 CRK CRKL RASGRP1 RASGRP3 TBC1D3I TBC1D3G VAV2 TBC1D3K TBC1D3F | 1.48e-13 | 335 | 124 | 19 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A TBC1D3C TBC1D3B TBC1D9 CRK CRKL RASGRP1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.57e-12 | 244 | 124 | 16 | GO:0043547 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A WRN TBC1D3C TBC1D3B TBC1D9 CRK CRKL RASGRP1 PTPRC AKT1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.52e-10 | 499 | 124 | 19 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A WRN PLXND1 CMYA5 TBC1D3C TBC1D3B TBC1D9 CRK CRKL RASGRP1 PTPRC RASGRP3 AKT1 TBC1D3I TBC1D3G VAV2 TBC1D3K TBC1D3F | 2.30e-09 | 878 | 124 | 23 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A WRN TSHR TBC1D3C TBC1D3B TBC1D9 CRK CRKL RASGRP1 IGF1R ARRB2 PTPRC AKT1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.93e-07 | 1028 | 124 | 22 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A WRN TSHR PLXND1 TBC1D3C TBC1D3B TBC1D9 CRK CRKL RASGRP1 IGF1R ARRB2 PTPRC SMARCA4 AKT1 PLCG2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.12e-06 | 1430 | 124 | 25 | GO:0044093 |
| GeneOntologyBiologicalProcess | calcium ion transport | TRPM6 ASIC1 CDH23 IBTK ARRB2 PTPRC PKD2L2 PRKACA AKT1 TRPM1 PLCG2 PLCH1 NALF2 | 1.22e-05 | 509 | 124 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | TRPM6 ASIC1 IBTK PTPRC PKD2L2 PRKACA AKT1 TRPM1 PLCG2 PLCH1 NALF2 | 2.52e-05 | 392 | 124 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | neuron projection development | KIF13B DSCAM MYO9A FAT3 RAB11A CDH23 TSHR PLXND1 ADGRV1 ATL1 CRK CRKL KIF3A SLITRK2 IGF1R PBRM1 NFIX AKT1 ULK2 TNXB | 8.04e-05 | 1285 | 124 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | helper T cell diapedesis | 1.07e-04 | 3 | 124 | 2 | GO:0035685 | |
| GeneOntologyBiologicalProcess | neuron development | KIF13B DSCAM MYO9A FAT3 RAB11A CDH23 TSHR PLXND1 ADGRV1 ATL1 CRK CRKL KIF3A SLITRK2 IGF1R PBRM1 NFIX AKT1 TRPM1 ULK2 TNXB | 1.63e-04 | 1463 | 124 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.87e-04 | 333 | 124 | 9 | GO:0051054 | |
| GeneOntologyBiologicalProcess | cerebellar neuron development | 2.13e-04 | 4 | 124 | 2 | GO:0098749 | |
| GeneOntologyBiologicalProcess | helper T cell extravasation | 2.13e-04 | 4 | 124 | 2 | GO:0035684 | |
| MousePheno | enlarged ovary | 2.05e-05 | 51 | 92 | 5 | MP:0004832 | |
| MousePheno | aberrant origin of the right subclavian artery | 6.21e-05 | 33 | 92 | 4 | MP:0010465 | |
| MousePheno | hydrocephaly | 6.93e-05 | 209 | 92 | 8 | MP:0001891 | |
| MousePheno | dilated third ventricle | 7.00e-05 | 34 | 92 | 4 | MP:0000827 | |
| MousePheno | abnormal CD8-positive, naive alpha-beta T cell number | 7.75e-05 | 67 | 92 | 5 | MP:0013434 | |
| MousePheno | abnormal positive T cell selection | 9.53e-05 | 14 | 92 | 3 | MP:0004919 | |
| MousePheno | abnormal aortic arch and aortic arch branch attachment | 9.83e-05 | 37 | 92 | 4 | MP:0010464 | |
| MousePheno | abnormal right subclavian artery morphology | 1.34e-04 | 40 | 92 | 4 | MP:0010487 | |
| MousePheno | abnormal third ventricle morphology | 1.60e-04 | 78 | 92 | 5 | MP:0000826 | |
| MousePheno | decreased outer hair cell stereocilia number | 2.10e-04 | 18 | 92 | 3 | MP:0004529 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D9 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.26e-14 | 49 | 121 | 11 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D9 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.22e-14 | 53 | 121 | 11 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D9 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.00e-14 | 55 | 121 | 11 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D9 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.00e-14 | 55 | 121 | 11 | PS50086 |
| Domain | HEAT | 3.66e-05 | 58 | 121 | 5 | IPR000357 | |
| Domain | Gln-Leu-Gln_QLQ | 4.16e-05 | 2 | 121 | 2 | IPR014978 | |
| Domain | SnAC | 4.16e-05 | 2 | 121 | 2 | PF14619 | |
| Domain | QLQ | 4.16e-05 | 2 | 121 | 2 | SM00951 | |
| Domain | QLQ | 4.16e-05 | 2 | 121 | 2 | PS51666 | |
| Domain | SnAC | 4.16e-05 | 2 | 121 | 2 | SM01314 | |
| Domain | SnAC | 4.16e-05 | 2 | 121 | 2 | IPR029295 | |
| Domain | QLQ | 4.16e-05 | 2 | 121 | 2 | PF08880 | |
| Domain | HEAT_REPEAT | 9.08e-05 | 70 | 121 | 5 | PS50077 | |
| Domain | BROMODOMAIN_1 | 9.38e-05 | 37 | 121 | 4 | PS00633 | |
| Domain | Bromodomain | 1.04e-04 | 38 | 121 | 4 | PF00439 | |
| Domain | P-loop_NTPase | KIF13B RAB11B KIF6 MYO9A MTG2 WRN RAB11A ATAD2 ATL1 KIF3A GPN2 MCM9 SMARCA2 SMARCA4 HELZ GNA15 | 1.17e-04 | 848 | 121 | 16 | IPR027417 |
| Domain | BROMODOMAIN_2 | 1.41e-04 | 41 | 121 | 4 | PS50014 | |
| Domain | Bromodomain | 1.55e-04 | 42 | 121 | 4 | IPR001487 | |
| Domain | BROMO | 1.55e-04 | 42 | 121 | 4 | SM00297 | |
| Domain | - | 1.55e-04 | 42 | 121 | 4 | 1.20.920.10 | |
| Domain | HSA | 2.48e-04 | 4 | 121 | 2 | SM00573 | |
| Domain | TRPM_tetra | 2.48e-04 | 4 | 121 | 2 | PF16519 | |
| Domain | HSA | 2.48e-04 | 4 | 121 | 2 | PS51204 | |
| Domain | TRPM_tetra | 2.48e-04 | 4 | 121 | 2 | IPR032415 | |
| Domain | HSA_dom | 2.48e-04 | 4 | 121 | 2 | IPR014012 | |
| Domain | HSA | 2.48e-04 | 4 | 121 | 2 | PF07529 | |
| Domain | HEAT | 2.62e-04 | 48 | 121 | 4 | PF02985 | |
| Domain | HAT_MYST-type | 4.11e-04 | 5 | 121 | 2 | IPR002717 | |
| Domain | GST_alpha | 4.11e-04 | 5 | 121 | 2 | IPR003080 | |
| Domain | MOZ_SAS | 4.11e-04 | 5 | 121 | 2 | PF01853 | |
| Domain | MYST_HAT | 4.11e-04 | 5 | 121 | 2 | PS51726 | |
| Domain | AGC-kinase_C | 4.75e-04 | 56 | 121 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.75e-04 | 56 | 121 | 4 | PS51285 | |
| Domain | S_TK_X | 4.75e-04 | 56 | 121 | 4 | SM00133 | |
| Domain | BRK | 6.14e-04 | 6 | 121 | 2 | SM00592 | |
| Domain | BRK_domain | 6.14e-04 | 6 | 121 | 2 | IPR006576 | |
| Domain | BRK | 6.14e-04 | 6 | 121 | 2 | PF07533 | |
| Domain | Bromodomain_CS | 6.18e-04 | 26 | 121 | 3 | IPR018359 | |
| Domain | ZF_DAG_PE_1 | 7.89e-04 | 64 | 121 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 7.89e-04 | 64 | 121 | 4 | PS50081 | |
| Domain | C1 | 8.37e-04 | 65 | 121 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 8.86e-04 | 66 | 121 | 4 | IPR002219 | |
| Domain | C2 | 1.63e-03 | 131 | 121 | 5 | PF00168 | |
| Domain | Arrestin-like_N | 1.81e-03 | 10 | 121 | 2 | IPR011021 | |
| Domain | Arrestin_C-like | 1.81e-03 | 10 | 121 | 2 | IPR011022 | |
| Domain | Arrestin_C | 1.81e-03 | 10 | 121 | 2 | SM01017 | |
| Domain | Arrestin_C | 1.81e-03 | 10 | 121 | 2 | PF02752 | |
| Domain | Arrestin_N | 1.81e-03 | 10 | 121 | 2 | PF00339 | |
| Domain | C2 | 1.99e-03 | 137 | 121 | 5 | SM00239 | |
| Domain | C2 | 2.32e-03 | 142 | 121 | 5 | PS50004 | |
| Domain | Kinesin_motor_CS | 2.36e-03 | 41 | 121 | 3 | IPR019821 | |
| Domain | Pkinase_C | 2.53e-03 | 42 | 121 | 3 | PF00433 | |
| Domain | Rho_GTPase_activation_prot | 2.57e-03 | 88 | 121 | 4 | IPR008936 | |
| Domain | EF-hand-dom_pair | 2.68e-03 | 287 | 121 | 7 | IPR011992 | |
| Domain | Kinesin-like_fam | 2.71e-03 | 43 | 121 | 3 | IPR027640 | |
| Domain | Kinase-like_dom | 2.77e-03 | 542 | 121 | 10 | IPR011009 | |
| Domain | - | 2.78e-03 | 148 | 121 | 5 | 2.60.40.150 | |
| Domain | - | 2.89e-03 | 44 | 121 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 2.89e-03 | 44 | 121 | 3 | PF00225 | |
| Domain | KISc | 2.89e-03 | 44 | 121 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.89e-03 | 44 | 121 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.89e-03 | 44 | 121 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.89e-03 | 44 | 121 | 3 | PS50067 | |
| Domain | H15 | 3.10e-03 | 13 | 121 | 2 | SM00526 | |
| Domain | H15 | 3.10e-03 | 13 | 121 | 2 | PS51504 | |
| Domain | - | 3.26e-03 | 222 | 121 | 6 | 1.25.10.10 | |
| Domain | - | RAB11B MTG2 WRN RAB11A ATAD2 ATL1 GPN2 MCM9 SMARCA2 SMARCA4 HELZ GNA15 | 3.31e-03 | 746 | 121 | 12 | 3.40.50.300 |
| Domain | Histone_H1/H5_H15 | 3.60e-03 | 14 | 121 | 2 | IPR005818 | |
| Domain | fn3 | 4.09e-03 | 162 | 121 | 5 | PF00041 | |
| Domain | TPR-like_helical_dom | 4.13e-03 | 233 | 121 | 6 | IPR011990 | |
| Domain | EF-hand_like | 4.14e-03 | 15 | 121 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 4.14e-03 | 15 | 121 | 2 | PF00387 | |
| Domain | PLCYc | 4.14e-03 | 15 | 121 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 4.14e-03 | 15 | 121 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 4.14e-03 | 15 | 121 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 4.14e-03 | 15 | 121 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 4.14e-03 | 15 | 121 | 2 | IPR015359 | |
| Domain | SH2 | 4.22e-03 | 101 | 121 | 4 | PF00017 | |
| Domain | C2_dom | 4.31e-03 | 164 | 121 | 5 | IPR000008 | |
| Domain | HEAT_type_2 | 5.31e-03 | 17 | 121 | 2 | IPR021133 | |
| Domain | SH2 | 5.71e-03 | 110 | 121 | 4 | SM00252 | |
| Domain | SH2 | 5.89e-03 | 111 | 121 | 4 | PS50001 | |
| Domain | PI-PLC-X | 5.95e-03 | 18 | 121 | 2 | PF00388 | |
| Domain | PLCXc | 5.95e-03 | 18 | 121 | 2 | SM00148 | |
| Domain | C1_1 | 6.02e-03 | 57 | 121 | 3 | PF00130 | |
| Domain | SH2 | 6.08e-03 | 112 | 121 | 4 | IPR000980 | |
| Domain | - | 6.08e-03 | 112 | 121 | 4 | 3.30.505.10 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 1.40e-08 | 99 | 91 | 9 | M46448 |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 2.76e-06 | 96 | 91 | 7 | M16121 | |
| Pathway | WP_B_CELL_RECEPTOR_SIGNALING | 2.96e-06 | 97 | 91 | 7 | M39323 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | CRK CRKL RASGRP1 ARRB2 PLA2G4B RASGRP3 PRKACA PRKACB RPS6KA6 AKT1 | 8.37e-06 | 267 | 91 | 10 | M10792 |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.38e-05 | 48 | 91 | 5 | M219 | |
| Pathway | WP_RAS_SIGNALING | 2.44e-05 | 184 | 91 | 8 | M39764 | |
| Pathway | WP_MAPK_SIGNALING | 2.93e-05 | 246 | 91 | 9 | M39597 | |
| Pathway | PID_TXA2PATHWAY | 2.96e-05 | 56 | 91 | 5 | M99 | |
| Pathway | PID_IGF1_PATHWAY | 3.41e-05 | 29 | 91 | 4 | M125 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 3.92e-05 | 30 | 91 | 4 | M42578 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 4.14e-05 | 11 | 91 | 3 | M47406 | |
| Pathway | PID_BCR_5PATHWAY | 5.25e-05 | 63 | 91 | 5 | M10 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 6.50e-05 | 34 | 91 | 4 | M210 | |
| Pathway | PID_ARF6_PATHWAY | 7.30e-05 | 35 | 91 | 4 | M86 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 7.30e-05 | 35 | 91 | 4 | M47969 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 1.12e-04 | 15 | 91 | 3 | MM15019 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.12e-04 | 15 | 91 | 3 | MM15103 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 1.37e-04 | 16 | 91 | 3 | M923 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.65e-04 | 43 | 91 | 4 | M39706 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 1.81e-04 | 44 | 91 | 4 | M42554 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 1.81e-04 | 44 | 91 | 4 | M9011 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 1.85e-04 | 184 | 91 | 7 | MM15943 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 2.11e-04 | 188 | 91 | 7 | M4844 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.19e-04 | 85 | 91 | 5 | M3578 | |
| Pathway | WP_RETT_SYNDROME | 2.54e-04 | 48 | 91 | 4 | M39759 | |
| Pathway | REACTOME_HEMOSTASIS | KIF13B KIF6 CRK KIF3A RASGRP1 ARRB2 PRKACA PRKACB AKT1 GNA15 PLCG2 VAV2 | 2.95e-04 | 571 | 91 | 12 | MM14472 |
| Pathway | WP_FOCAL_ADHESION | 2.99e-04 | 199 | 91 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.99e-04 | 199 | 91 | 7 | M7253 | |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 3.67e-04 | 22 | 91 | 3 | MM1438 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 4.02e-04 | 54 | 91 | 4 | M17906 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 4.07e-04 | 5 | 91 | 2 | M26988 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 4.07e-04 | 5 | 91 | 2 | M26921 | |
| Pathway | WP_CANCER_PATHWAYS | CRK CRKL GSTA1 GSTA2 RASGRP1 IGF1R RASGRP3 PRKACA PRKACB AKT1 PLCG2 | 4.10e-04 | 507 | 91 | 11 | M48302 |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 4.20e-04 | 23 | 91 | 3 | M19613 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 4.20e-04 | 23 | 91 | 3 | M45013 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 4.77e-04 | 24 | 91 | 3 | MM1467 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 5.34e-04 | 103 | 91 | 5 | MM14752 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 5.40e-04 | 25 | 91 | 3 | M85 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 5.86e-04 | 160 | 91 | 6 | MM15990 | |
| Pathway | WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING | 6.08e-04 | 6 | 91 | 2 | M39742 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 6.08e-04 | 6 | 91 | 2 | MM14628 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 6.09e-04 | 106 | 91 | 5 | M27077 | |
| Pathway | WP_THERMOGENESIS | 6.63e-04 | 108 | 91 | 5 | M39746 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 6.80e-04 | 27 | 91 | 3 | MM15693 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 6.80e-04 | 27 | 91 | 3 | M760 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 6.89e-04 | 165 | 91 | 6 | M39400 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 7.21e-04 | 110 | 91 | 5 | M48043 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 7.24e-04 | 63 | 91 | 4 | M39646 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 7.24e-04 | 63 | 91 | 4 | M39884 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 7.58e-04 | 28 | 91 | 3 | M252 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 7.58e-04 | 28 | 91 | 3 | MM14958 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 8.15e-04 | 65 | 91 | 4 | M39682 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 8.42e-04 | 29 | 91 | 3 | M39762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 8.42e-04 | 29 | 91 | 3 | M47627 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 8.47e-04 | 7 | 91 | 2 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 8.47e-04 | 7 | 91 | 2 | MM15560 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 8.63e-04 | 66 | 91 | 4 | MM15875 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 9.16e-04 | 116 | 91 | 5 | MM15715 | |
| Pathway | PID_AURORA_A_PATHWAY | 1.03e-03 | 31 | 91 | 3 | M242 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.03e-03 | 31 | 91 | 3 | MM15094 | |
| Pathway | KEGG_ENDOCYTOSIS | 1.11e-03 | 181 | 91 | 6 | M1519 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 1.13e-03 | 8 | 91 | 2 | M27840 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 1.14e-03 | 71 | 91 | 4 | MM15947 | |
| Pathway | PID_EPO_PATHWAY | 1.23e-03 | 33 | 91 | 3 | M233 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 1.23e-03 | 33 | 91 | 3 | M277 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.33e-03 | 126 | 91 | 5 | M16763 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.35e-03 | 34 | 91 | 3 | M177 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 1.36e-03 | 257 | 91 | 7 | MM15454 | |
| Pathway | REACTOME_HEMOSTASIS | KIF13B KIF6 CRK KIF3A RASGRP1 ARRB2 PRKACA PRKACB AKT1 GNA15 PLCG2 VAV2 | 1.36e-03 | 679 | 91 | 12 | M8395 |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.39e-03 | 75 | 91 | 4 | M5436 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 1.44e-03 | 9 | 91 | 2 | M27877 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 1.44e-03 | 9 | 91 | 2 | MM15666 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.47e-03 | 35 | 91 | 3 | M249 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.47e-03 | 35 | 91 | 3 | MM15109 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 1.48e-03 | 261 | 91 | 7 | M1077 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.49e-03 | 418 | 91 | 9 | MM15587 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.59e-03 | 36 | 91 | 3 | M1315 | |
| Pathway | PID_MET_PATHWAY | 1.69e-03 | 79 | 91 | 4 | M48 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 1.69e-03 | 79 | 91 | 4 | M11816 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.73e-03 | 37 | 91 | 3 | M27797 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 1.79e-03 | 10 | 91 | 2 | M27777 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 1.79e-03 | 10 | 91 | 2 | M47648 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 1.79e-03 | 10 | 91 | 2 | MM15516 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 1.79e-03 | 10 | 91 | 2 | M39469 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.86e-03 | 38 | 91 | 3 | MM15456 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.92e-03 | 137 | 91 | 5 | M18155 | |
| Pathway | PID_REG_GR_PATHWAY | 1.94e-03 | 82 | 91 | 4 | M115 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 2.01e-03 | 39 | 91 | 3 | M10735 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.01e-03 | 39 | 91 | 3 | MM14496 | |
| Pathway | PID_ECADHERIN_NASCENT_AJ_PATHWAY | 2.01e-03 | 39 | 91 | 3 | M156 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 2.16e-03 | 40 | 91 | 3 | M41 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 2.16e-03 | 40 | 91 | 3 | MM15115 | |
| Pathway | PID_IFNG_PATHWAY | 2.16e-03 | 40 | 91 | 3 | M161 | |
| Pathway | REACTOME_MET_ACTIVATES_RAP1_AND_RAC1 | 2.18e-03 | 11 | 91 | 2 | M27776 | |
| Pathway | REACTOME_MET_ACTIVATES_RAP1_AND_RAC1 | 2.18e-03 | 11 | 91 | 2 | MM15515 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 2.18e-03 | 11 | 91 | 2 | M47484 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 2.32e-03 | 41 | 91 | 3 | MM15162 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.40e-03 | 87 | 91 | 4 | M12467 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 2.61e-03 | 12 | 91 | 2 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 2.61e-03 | 12 | 91 | 2 | M27363 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.51e-28 | 11 | 124 | 11 | 16863688 |
| Pubmed | TRPM6 KAT6A PLXND1 CRK CRKL KIF3A IGF1R PLA2G4B PRKACA PRKACB RPS6KA6 SMARCA2 SMARCA4 ADAM33 AKT1 KAT6B ULK2 ATP6V0A2 | 1.31e-10 | 730 | 124 | 18 | 34857952 | |
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 12604796 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 9.11e-09 | 74 | 124 | 7 | 16625196 | |
| Pubmed | 7.45e-08 | 12 | 124 | 4 | 15140983 | ||
| Pubmed | Rab11 and its effector Rip11 participate in regulation of insulin granule exocytosis. | 1.76e-07 | 4 | 124 | 3 | 19335615 | |
| Pubmed | FIP5 phosphorylation during mitosis regulates apical trafficking and lumenogenesis. | 1.76e-07 | 4 | 124 | 3 | 24591568 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.76e-07 | 4 | 124 | 3 | 12359748 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 15522217 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 8406013 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 19596798 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 8471161 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 19483721 | ||
| Pubmed | Structural and functional analysis of FIP2 binding to the endosome-localised Rab25 GTPase. | 4.40e-07 | 5 | 124 | 3 | 24056041 | |
| Pubmed | Proapoptotic function of the nuclear Crk II adaptor protein. | 8.78e-07 | 6 | 124 | 3 | 17764157 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBR2 MYO9A VPS13C KIAA0232 KAT6A TTC14 ADGRV1 DNAAF5 AP1S1 IGF1R ARRB2 NFIX PRKACB SMARCA2 ENPP5 ZFHX3 KAT6B ARHGAP8 VAV2 | 1.41e-06 | 1489 | 124 | 19 | 28611215 |
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 8621483 | ||
| Pubmed | Akt Regulates a Rab11-Effector Switch Required for Ciliogenesis. | 1.53e-06 | 7 | 124 | 3 | 31204173 | |
| Pubmed | Identification of a novel Rab11/25 binding domain present in Eferin and Rip proteins. | 1.53e-06 | 7 | 124 | 3 | 11481332 | |
| Pubmed | 1.55e-06 | 24 | 124 | 4 | 20624904 | ||
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 16982329 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 5.73e-06 | 71 | 124 | 5 | 28319113 | |
| Pubmed | Identification and characterization of a family of Rab11-interacting proteins. | 7.15e-06 | 11 | 124 | 3 | 11495908 | |
| Pubmed | MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues. | 9.51e-06 | 12 | 124 | 3 | 8297798 | |
| Pubmed | MYO9A CFAP36 KIAA0232 FAM13B KIF3A ARRB2 PRKACA HELZ PRKDC TBC1D3F | 1.02e-05 | 486 | 124 | 10 | 20936779 | |
| Pubmed | 1.23e-05 | 13 | 124 | 3 | 19895210 | ||
| Pubmed | Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma. | 1.26e-05 | 2 | 124 | 2 | 21319228 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18439899 | ||
| Pubmed | Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway. | 1.26e-05 | 2 | 124 | 2 | 19074029 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8670841 | ||
| Pubmed | Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. | 1.26e-05 | 2 | 124 | 2 | 22569336 | |
| Pubmed | Importance of the REM (Ras exchange) domain for membrane interactions by RasGRP3. | 1.26e-05 | 2 | 124 | 2 | 28912101 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11668220 | ||
| Pubmed | Physiological signals and oncogenesis mediated through Crk family adapter proteins. | 1.26e-05 | 2 | 124 | 2 | 10092207 | |
| Pubmed | Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. | 1.26e-05 | 2 | 124 | 2 | 17065200 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23163725 | ||
| Pubmed | Human liver glutathione S-transferases: complete primary sequence of an Ha subunit cDNA. | 1.26e-05 | 2 | 124 | 2 | 3800996 | |
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 1.26e-05 | 2 | 124 | 2 | 3023318 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15192111 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.26e-05 | 2 | 124 | 2 | 23076393 | |
| Pubmed | Nucleotide sequence of the human liver glutathione S-transferase subunit 1 cDNA. | 1.26e-05 | 2 | 124 | 2 | 3678589 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15576411 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24499776 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15240517 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.26e-05 | 2 | 124 | 2 | 33027072 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23872584 | ||
| Pubmed | The basic glutathione S-transferases from human livers are products of separate genes. | 1.26e-05 | 2 | 124 | 2 | 3036131 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.26e-05 | 2 | 124 | 2 | 23088494 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26637356 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20333683 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34812766 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21163259 | ||
| Pubmed | TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease. | 1.26e-05 | 2 | 124 | 2 | 39082947 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15128049 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.26e-05 | 2 | 124 | 2 | 30478150 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7478571 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11692074 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18768899 | ||
| Pubmed | Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL). | 1.26e-05 | 2 | 124 | 2 | 27807028 | |
| Pubmed | DNA damage promotes microtubule dynamics through a DNA-PK-AKT axis for enhanced repair. | 1.26e-05 | 2 | 124 | 2 | 33404607 | |
| Pubmed | CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML. | 1.26e-05 | 2 | 124 | 2 | 38683131 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 1.26e-05 | 2 | 124 | 2 | 25808524 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 36152045 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 38841868 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18728011 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26389690 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19144640 | ||
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 1.26e-05 | 2 | 124 | 2 | 19144648 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33561443 | ||
| Pubmed | A role for Rab11 in the homeostasis of the endosome-lysosomal pathway. | 1.26e-05 | 2 | 124 | 2 | 30981667 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 1.26e-05 | 2 | 124 | 2 | 29391527 | |
| Pubmed | Crk and CrkL are required for cell transformation by v-fos and v-ras. | 1.26e-05 | 2 | 124 | 2 | 25557916 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 39505971 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 37634210 | ||
| Pubmed | Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. | 1.26e-05 | 2 | 124 | 2 | 12139926 | |
| Pubmed | Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. | 1.26e-05 | 2 | 124 | 2 | 15262962 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8208605 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18165234 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 2604726 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 2833513 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 1.26e-05 | 2 | 124 | 2 | 11163203 | |
| Pubmed | A Rab11/Rip11 protein complex regulates apical membrane trafficking via recycling endosomes. | 1.26e-05 | 2 | 124 | 2 | 11163216 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 1.26e-05 | 2 | 124 | 2 | 12620226 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16478996 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27039070 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29848589 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24150941 | ||
| Pubmed | The human thyrotropin receptor is predominantly internalized by beta-arrestin 2. | 1.26e-05 | 2 | 124 | 2 | 16513835 | |
| Pubmed | DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance. | 1.26e-05 | 2 | 124 | 2 | 22131882 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 3031680 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12646569 | ||
| Pubmed | β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein. | 1.26e-05 | 2 | 124 | 2 | 26582201 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22251701 | ||
| Pubmed | Global consequences of activation loop phosphorylation on protein kinase A. | 1.26e-05 | 2 | 124 | 2 | 19965870 | |
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 1.26e-05 | 2 | 124 | 2 | 9603422 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23276717 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27097303 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28038711 | ||
| Pubmed | Requirement for Crk and CrkL during postnatal lens development. | 1.26e-05 | 2 | 124 | 2 | 32736680 | |
| Interaction | SNX16 interactions | 1.93e-06 | 16 | 118 | 4 | int:SNX16 | |
| Interaction | PMS2 interactions | 7.48e-06 | 80 | 118 | 6 | int:PMS2 | |
| Interaction | CIITA interactions | 1.74e-05 | 55 | 118 | 5 | int:CIITA | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.57e-13 | 149 | 124 | 11 | chr17q12 |
| Cytoband | 17q12 | 7.74e-06 | 99 | 124 | 5 | 17q12 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 7.40e-05 | 19 | 79 | 3 | 832 | |
| GeneFamily | Transient receptor potential cation channels | 2.43e-04 | 28 | 79 | 3 | 249 | |
| GeneFamily | Fibronectin type III domain containing | 6.78e-04 | 160 | 79 | 5 | 555 | |
| GeneFamily | Phospholipases | 8.15e-04 | 42 | 79 | 3 | 467 | |
| GeneFamily | SH2 domain containing | 1.00e-03 | 101 | 79 | 4 | 741 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.06e-03 | 46 | 79 | 3 | 622 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 2.17e-03 | 16 | 79 | 2 | 66 | |
| GeneFamily | Cadherin related | 2.46e-03 | 17 | 79 | 2 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.46e-03 | 17 | 79 | 2 | 486 | |
| GeneFamily | EF-hand domain containing | 2.71e-03 | 219 | 79 | 5 | 863 | |
| GeneFamily | Glutathione S-transferases | 5.30e-03 | 25 | 79 | 2 | 567 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.16e-03 | 27 | 79 | 2 | 47 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYO9A CFAP36 VPS13C WRN XPO1 ATAD2 TTK FAM13B TBC1D9 ATL1 KIF3A PBRM1 SACS SYNE2 SMARCA2 TRPM1 | 6.20e-08 | 656 | 121 | 16 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | UBR2 KAT6A WRN CKAP5 XPO1 TTK PTPN2 IBTK IGF1R SACS SYNE2 PRKACB SMARCA2 HELZ ZFHX3 KAT6B | 2.12e-06 | 856 | 121 | 16 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | UBR2 KAT6A WRN CKAP5 XPO1 PTPN2 IBTK PRKACB SMARCA2 HELZ KAT6B | 1.10e-05 | 466 | 121 | 11 | M13522 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | NRAP ASIC1 MYO9A VPS13C KAT6A CPA1 ADGRV1 TBC1D3B IGF1R PKD2L2 ADAM5 MCM9 TBC1D3I TBC1D3G TBC1D3F | 1.24e-05 | 873 | 121 | 15 | M16009 |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | 1.81e-05 | 176 | 121 | 7 | M7725 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP | 3.98e-05 | 199 | 121 | 7 | M6420 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 2.25e-09 | 90 | 121 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G NALF2 TBC1D3K TBC1D3F | 4.01e-07 | 213 | 121 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G NALF2 TBC1D3K TBC1D3F | 4.01e-07 | 213 | 121 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SLITRK2 TBC1D3G TBC1D3K TBC1D3F | 1.28e-06 | 242 | 121 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PLCG2 TBC1D3G TBC1D3K TBC1D3F | 1.52e-05 | 320 | 121 | 10 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.40e-05 | 281 | 121 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.40e-05 | 281 | 121 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | CPPED1 TBC1D3 NRAP TBC1D3H TBC1D3L TBC1D3D MYO9A TBC1D3C TBC1D3B GSTA1 GSTA2 RAB11FIP5 ARHGAP8 TBC1D3G VAV2 TBC1D3K TBC1D3F | 9.44e-05 | 1049 | 121 | 17 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-08 | 161 | 124 | 8 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.94e-07 | 96 | 124 | 6 | a48235df1f5526ce3ffc4c0c2ba038eb20229c55 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.94e-07 | 96 | 124 | 6 | 0fc179af7370a29b7bd5d81e1302a479ae72f196 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.94e-07 | 96 | 124 | 6 | c301ecfd67ece8bb12be1b94b614957a58046457 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.94e-07 | 96 | 124 | 6 | 7d402d543ff159c9bb84c00b083e6e18fc0ff786 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-07 | 165 | 124 | 7 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.54e-07 | 115 | 124 | 6 | 15b2c11225802cc15c01165d84a755432f02d82f | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.10e-06 | 191 | 124 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.14e-06 | 192 | 124 | 7 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.14e-06 | 192 | 124 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-06 | 197 | 124 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.50e-06 | 200 | 124 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-06 | 154 | 124 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-06 | 154 | 124 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.43e-06 | 167 | 124 | 6 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 172 | 124 | 6 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 176 | 124 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-05 | 181 | 124 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 182 | 124 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.33e-05 | 185 | 124 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.37e-05 | 186 | 124 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.41e-05 | 187 | 124 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.50e-05 | 189 | 124 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.50e-05 | 189 | 124 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 191 | 124 | 6 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-05 | 191 | 124 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.69e-05 | 193 | 124 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.90e-05 | 197 | 124 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.95e-05 | 198 | 124 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.95e-05 | 198 | 124 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.95e-05 | 198 | 124 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.51e-05 | 151 | 124 | 5 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.14e-05 | 154 | 124 | 5 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.76e-05 | 81 | 124 | 4 | 2c58dbad21e0fbe46b005bcaf45139d098a2057a | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.76e-05 | 81 | 124 | 4 | a0b45dc22077805eba94689568b874415f515d61 | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.76e-05 | 81 | 124 | 4 | 571884bcf4282053c6170609ae0c794a6df05cd9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.07e-05 | 162 | 124 | 5 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 167 | 124 | 5 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 168 | 124 | 5 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 168 | 124 | 5 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 169 | 124 | 5 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 170 | 124 | 5 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.27e-04 | 174 | 124 | 5 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.30e-04 | 175 | 124 | 5 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Large_pre-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 176 | 124 | 5 | 78417a5ac2e45e97e7b4c56c78c25879a1b58f97 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-04 | 177 | 124 | 5 | 2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-04 | 178 | 124 | 5 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-04 | 178 | 124 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 179 | 124 | 5 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 181 | 124 | 5 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 181 | 124 | 5 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.56e-04 | 182 | 124 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.56e-04 | 182 | 124 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-04 | 184 | 124 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 185 | 124 | 5 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.69e-04 | 185 | 124 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-04 | 186 | 124 | 5 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-04 | 187 | 124 | 5 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 187 | 124 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 187 | 124 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.82e-04 | 188 | 124 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.82e-04 | 188 | 124 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.82e-04 | 188 | 124 | 5 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.86e-04 | 189 | 124 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 189 | 124 | 5 | feedac2751ed770f80bc56fec31662b5b3826f58 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 189 | 124 | 5 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.86e-04 | 189 | 124 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | moderate-Epithelial-Ciliated-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-04 | 191 | 124 | 5 | 6cdc6a0c0a1ce5a1ef550832319847f62e718975 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.96e-04 | 191 | 124 | 5 | 3e84c453e8a151c42808fe2935f1d732e180008c | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 1.96e-04 | 191 | 124 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-04 | 191 | 124 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-04 | 191 | 124 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 1.96e-04 | 191 | 124 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 192 | 124 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 192 | 124 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.05e-04 | 193 | 124 | 5 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.05e-04 | 193 | 124 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.05e-04 | 193 | 124 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 193 | 124 | 5 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 193 | 124 | 5 | de0213f2105b814f38ffbfd004ea7603230eed68 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 2.10e-04 | 194 | 124 | 5 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.10e-04 | 194 | 124 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.10e-04 | 194 | 124 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 194 | 124 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.15e-04 | 195 | 124 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.15e-04 | 195 | 124 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.15e-04 | 195 | 124 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.15e-04 | 195 | 124 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.21e-04 | 196 | 124 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-04 | 196 | 124 | 5 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.21e-04 | 196 | 124 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-04 | 197 | 124 | 5 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.26e-04 | 197 | 124 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-04 | 197 | 124 | 5 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.12e-08 | 195 | 114 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.12e-06 | 24 | 114 | 4 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.12e-06 | 24 | 114 | 4 | C3805278 | |
| Disease | Cholangiocarcinoma | 2.96e-06 | 26 | 114 | 4 | C0206698 | |
| Disease | Prostatic Neoplasms | NAT1 KAT6A UNC13D XPO1 GSTA1 PTPRC PRKACB ENPP5 AKT1 ZFHX3 PRKDC | 2.77e-05 | 616 | 114 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | NAT1 KAT6A UNC13D XPO1 GSTA1 PTPRC PRKACB ENPP5 AKT1 ZFHX3 PRKDC | 2.77e-05 | 616 | 114 | 11 | C0376358 |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 5.20e-05 | 19 | 114 | 3 | DOID:11198 (implicated_via_orthology) | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.35e-05 | 53 | 114 | 4 | C1961099 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.47e-04 | 5 | 114 | 2 | C3281201 | |
| Disease | urate measurement, bone density | 1.48e-04 | 619 | 114 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | mean platelet volume | CFAP251 AOC1 KIAA0232 UNC13D PLXND1 CRKL PTPRC SYNE2 MCM9 ZNF778 TTC13 PLCG2 ULK2 | 1.61e-04 | 1020 | 114 | 13 | EFO_0004584 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.10e-04 | 139 | 114 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Cushing Syndrome | 2.20e-04 | 6 | 114 | 2 | C0010481 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.57e-04 | 32 | 114 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 3.07e-04 | 7 | 114 | 2 | EFO_0800400 | |
| Disease | sex interaction measurement, Crohn's disease | 3.97e-04 | 37 | 114 | 3 | EFO_0000384, EFO_0008343 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 5.23e-04 | 9 | 114 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | atrial fibrillation | 6.11e-04 | 371 | 114 | 7 | EFO_0000275 | |
| Disease | Adrenal Gland Neoplasms | 7.95e-04 | 11 | 114 | 2 | C0001624 | |
| Disease | Adrenal Cancer | 7.95e-04 | 11 | 114 | 2 | C0750887 | |
| Disease | pancreatic cancer (is_implicated_in) | 9.52e-04 | 112 | 114 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | N-acetylputrescine measurement | 9.52e-04 | 12 | 114 | 2 | EFO_0800127 | |
| Disease | late-onset Alzheimers disease | 9.74e-04 | 292 | 114 | 6 | EFO_1001870 | |
| Disease | serum IgG glycosylation measurement | 9.85e-04 | 523 | 114 | 8 | EFO_0005193 | |
| Disease | Coffin-Siris syndrome | 1.12e-03 | 13 | 114 | 2 | C0265338 | |
| Disease | lymphocyte percentage of leukocytes | 1.13e-03 | 665 | 114 | 9 | EFO_0007993 | |
| Disease | Small cell carcinoma of lung | 1.21e-03 | 54 | 114 | 3 | C0149925 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 1.27e-03 | 55 | 114 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | ovarian cancer (is_implicated_in) | 1.34e-03 | 56 | 114 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | 1,3,7-trimethylurate measurement | 1.50e-03 | 15 | 114 | 2 | EFO_0021172 | |
| Disease | Malignant Neoplasms | 1.56e-03 | 128 | 114 | 4 | C0006826 | |
| Disease | thyroid volume | 1.71e-03 | 16 | 114 | 2 | EFO_0004865 | |
| Disease | sphingomyelin 14:0 measurement | 1.94e-03 | 17 | 114 | 2 | EFO_0010390 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 1.94e-03 | 17 | 114 | 2 | OBA_2045173 | |
| Disease | C-X-C motif chemokine 16 measurement | 2.17e-03 | 18 | 114 | 2 | EFO_0010911 | |
| Disease | C-C motif chemokine 3 measurement | 2.17e-03 | 18 | 114 | 2 | EFO_0008051 | |
| Disease | Meningioma | 2.42e-03 | 19 | 114 | 2 | C0025286 | |
| Disease | breast size | 2.44e-03 | 69 | 114 | 3 | EFO_0004884 | |
| Disease | neutrophil count | UBR2 DSCAM RAB11A CDH23 TSHR XPO1 CRK PTPRC AKT1 GNA15 PRKDC TNXB ATP6V0A2 | 2.65e-03 | 1382 | 114 | 13 | EFO_0004833 |
| Disease | CCL4 measurement | 2.69e-03 | 20 | 114 | 2 | EFO_0004751 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 2.69e-03 | 20 | 114 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Severe Combined Immunodeficiency | 2.69e-03 | 20 | 114 | 2 | C0085110 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 2.96e-03 | 21 | 114 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 2.96e-03 | 21 | 114 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | Paroxysmal atrial fibrillation | 3.20e-03 | 156 | 114 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.20e-03 | 156 | 114 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.20e-03 | 156 | 114 | 4 | C2585653 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin | 3.25e-03 | 22 | 114 | 2 | EFO_0004509, EFO_0004527 | |
| Disease | Corneal astigmatism | 3.34e-03 | 77 | 114 | 3 | EFO_1002040 | |
| Disease | Atrial Fibrillation | 3.50e-03 | 160 | 114 | 4 | C0004238 | |
| Disease | Neoplasm of the genitourinary tract | 3.86e-03 | 24 | 114 | 2 | cv:C0042065 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDYLHSEKNVVYRDL | 261 | P31749 | |
| LHSDLLEDSKYRKIY | 176 | P18440 | |
| HKIYEEKYADTNILL | 106 | Q6NVV9 | |
| DEIIHKYLYELEHAL | 576 | Q8NDM7 | |
| KYLYELEHALSSAVL | 581 | Q8NDM7 | |
| TYHTLEEIYDFLDLL | 121 | P15085 | |
| SKLTYTEIHQEYKEL | 46 | Q96G28 | |
| HLLTLSLDLYYTEDE | 411 | O95267 | |
| YERKLTLEEIYELHA | 1486 | Q8WXG9 | |
| LELIHRYVELLDKYF | 81 | P61966 | |
| YLELYIVADHTLFLT | 211 | Q9BZ11 | |
| YEHSVTLESLLYLIE | 316 | Q008S8 | |
| HKYLTVKDYLRDIDL | 1041 | Q6PL18 | |
| AEYALLYHTLQEATK | 146 | P19801 | |
| DLTELTYLYLDHNKV | 121 | O15335 | |
| GDTLYLAVHLLDSYL | 126 | Q9H8S5 | |
| KELDYEISHGRYTLI | 1696 | Q9H251 | |
| RSLHLEASLDKELYY | 196 | P32121 | |
| SLIHIDYYLQVSLKA | 256 | Q8N5I2 | |
| TEELYSYLKEFIHIL | 61 | Q9NZ32 | |
| EYDLLRSYKDHLEVL | 771 | Q8TBY9 | |
| LEFYKIHYLDTTTLI | 101 | P46108 | |
| GALLVYDIAKHLTYE | 86 | P62491 | |
| GALLVYDIAKHLTYE | 86 | Q15907 | |
| KLYTVDLESGLHYLL | 321 | Q6ZRP7 | |
| KYYHLTHDELISLLL | 596 | Q9BXF6 | |
| ADIHLVELLYYVEEL | 156 | P08263 | |
| DELVLYYKKILSLHA | 501 | Q86VS3 | |
| LSEDVKSYYTVHLLQ | 146 | P17706 | |
| LLAKLFLDHKTLYYD | 806 | Q8WYB5 | |
| TQRLLHSEAYLKYIE | 1601 | Q86U86 | |
| IVLTFEYLHSLDLIY | 151 | P17612 | |
| TIKELDLYLAYFVHT | 171 | Q14938 | |
| YTEVLDLSYLLDHLA | 196 | Q9H9Y4 | |
| LASDLDYRKKLHEYT | 646 | Q86VF7 | |
| HSDILKVILDYLYTD | 816 | Q9P2D0 | |
| LLSYEDLELAVGHLY | 476 | Q96T76 | |
| EEYLLFDSDKLSHLI | 416 | Q9NYF5 | |
| DIDSYILYHLLEDSA | 191 | P50747 | |
| ADIHLVELLYYVEEL | 156 | P09210 | |
| EGYLHILLISKAEDY | 56 | P08069 | |
| SLLTIALHGKLEYYT | 1446 | Q9Y4D7 | |
| VLSLLLHDSYDYDLQ | 61 | Q92628 | |
| KYLDDIHLSELTHFY | 496 | Q92628 | |
| KTAKYNYDILLLEHS | 8321 | Q7Z5P9 | |
| ELDQYLDKDHYTLID | 251 | Q9UJA9 | |
| LLTEAKYINLSLHYL | 266 | Q6ZMV9 | |
| YEQLDVLKHKLDELY | 346 | Q13421 | |
| HLLLIAIEYKSLFTD | 551 | A8MYU2 | |
| LHYLYTSEIALDEAS | 86 | Q2TBA0 | |
| SDILYVISKTVDYLH | 521 | Q9UK32 | |
| LVLHKYLQAEEYSIR | 266 | O75949 | |
| YSQEDVDKLLHLTHY | 741 | P0C869 | |
| ESLVELVSYYEKHSL | 711 | P16885 | |
| LLDSAVYYLSHLERI | 156 | P30679 | |
| EFYKIHYLDTTTLIE | 86 | P46109 | |
| VDLSHVYLAYTEESL | 646 | Q9Y496 | |
| YQSRLHDLLYIEEIA | 456 | P42694 | |
| LHRGTEKLIEYKTYL | 116 | O75306 | |
| DTLLLEKHADYIASY | 16 | P53611 | |
| LAKLFLDHKTLYYDV | 596 | Q92794 | |
| EYLKLLFTLLSEEEY | 1266 | Q14008 | |
| IVLTFEYLHSLDLIY | 151 | P22694 | |
| LESEIDELYIQYIKH | 421 | Q8WXF7 | |
| IYFEKYILKDDILHD | 3236 | Q8N3K9 | |
| REHTDLYLLNITIYD | 791 | Q8TDW7 | |
| EKIVHRYYSLDELSE | 286 | Q9BRF8 | |
| SVQYLYRELLVHLDD | 786 | Q86Y56 | |
| ENLSYDAKLEHLIYL | 3486 | Q9NZJ4 | |
| GLSILLESYYEHEVR | 96 | Q3MIP1 | |
| YVSEYHKNDILLILK | 16 | Q9NXL9 | |
| LLIKHVVEEDSGYYL | 751 | O60469 | |
| ELLVYYLKEHTLIGS | 461 | Q9NQT8 | |
| LLTTYEYIIKDKHIL | 826 | P51531 | |
| VHYETLALELKKLYL | 4566 | Q8WXH0 | |
| TLSLDLYHTEDDIYK | 361 | Q8IV61 | |
| LYHTEDDIYKLSLVL | 366 | Q8IV61 | |
| LLTTYEYIIKDKHIL | 856 | P51532 | |
| YKNDLLEYSSLDLLH | 391 | Q9H156 | |
| LLLHLKVLYDAYAEA | 381 | Q9H4K7 | |
| EEYLSDIAYKSTEHL | 411 | Q14191 | |
| DELLHAYSKVYTLDI | 396 | Q969I6 | |
| KQRELLHILLAYEEY | 166 | B9A6J9 | |
| YLLNLKEHLEDIYVG | 196 | A8MXE2 | |
| LELFDYAYEVIKHKL | 451 | P78348 | |
| EINTYKAIHLDLEEY | 306 | Q96KN2 | |
| VDLYILTYQAEKALH | 156 | Q9H9A5 | |
| VDLTNHLEYTLKTYI | 346 | Q9BXU1 | |
| KQRELLHILLAYEEY | 166 | A6NDS4 | |
| KQRELLHILLAYEEY | 166 | P0C7X1 | |
| LVYLTHLDYVDTERI | 461 | O14980 | |
| QLYHAEIDALYKDLT | 716 | Q8NBP0 | |
| YLLKEHLKTYTEEQV | 686 | Q96MU6 | |
| YIRTSYDTKLDHLLH | 111 | Q9BX84 | |
| DDTIRYLSLHDNKYI | 86 | Q6UXN9 | |
| KQRELLHILLAYEEY | 166 | A6NER0 | |
| LTFEKSRYETYIHLL | 701 | Q9BQI7 | |
| LSGLESDHRYLVTLY | 1936 | P22105 | |
| ELEELYALFKAEHLT | 826 | Q6ZT07 | |
| SASEEYLKENHILEY | 916 | Q6P2S7 | |
| YLKENHILEYATEIS | 921 | Q6P2S7 | |
| IDRYHEKLAVSLYSS | 196 | Q96N46 | |
| VSYLKKISLDYHEIE | 956 | Q709C8 | |
| KQRELLHILLAYEEY | 166 | A0A087X179 | |
| LFLYAVELEKELHYI | 596 | Q9NZM6 | |
| DLYLLLLSYSDKKDH | 216 | Q4KWH8 | |
| AILELHYSQELSLLY | 3076 | P78527 | |
| SHELDHQRLLEYLKY | 46 | P85298 | |
| YHISLIDIGLVLEYL | 526 | Q7Z4N2 | |
| EDIVYRYHKAALLLE | 986 | Q8IYT8 | |
| HSDKIIRLYDYEITD | 581 | P33981 | |
| KQRELLHILLAYEEY | 166 | A0A087WVF3 | |
| LLRHLYAKDDYELID | 1526 | Q6PGP7 | |
| GYSYELKEIIELLFH | 441 | P52735 | |
| LRKNLAEEYLHYLSE | 176 | Q2TAA8 | |
| EESAVLALYKTLHQY | 1476 | Q8IWV8 | |
| KQRELLHILLAYEEY | 166 | Q6DHY5 | |
| KQRELLHILLAYEEY | 166 | Q8IZP1 | |
| SIALLVVLYKIYDLH | 591 | P08575 | |
| QRALLYEDALYTVLH | 51 | Q70J99 | |
| KQRELLHILLAYEEY | 166 | A0A087X1G2 | |
| YLTLLDDEDHKLEYL | 676 | Q8NFA0 | |
| KQRELLHILLAYEEY | 166 | A0A087WXS9 | |
| KQRELLHILLAYEEY | 166 | Q6IPX1 | |
| AAELESIYYSLHKIQ | 51 | Q9H808 | |
| QDLYTVLHKTEDYLR | 271 | Q9Y487 | |
| DYYTNSLEKLRLHTV | 1046 | Q15911 | |
| YLLLIASVDLYTHSE | 466 | P16473 | |
| EKYLLEKSRLVYQEH | 316 | B2RTY4 |